EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-SA 4.0

Assessing the Effectiveness of Hormonal Aromatase inhibitors (AI) Therapy in Hormone Receptor Positive Post-Menopausal Breast Cancer Patients: A Systematic Review

Angki Perdiyana, Agri Lesmana, Dea Syafira Alamsyah Sitompul, Fakhira Ayu Wijayanti, Miko Dharma Alrasyid, Naufal Yafi Rais Wiguna, Tharisa Novianti Syabania Sutomo, Deity Nugraha, Elies Fitriani

Bali Medical and Wellness Journal · 2024

DOI: 10.71341/bmwj.v1i2.7 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Bali Medical and Wellness Journal, 2024. Verfasst von Angki Perdiyana und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endocrine therapy is a cornerstone in the treatment of breast cancer for patients who are hormone receptor-positive (HR+). Aromatase Inhibitors are a key option for managing HR+ breast cancer in postmenopausal women.

Objective

This study investigates the efficacy of Aromatase Inhibitors in postmenopausal women with HR+ breast cancer, focusing on their therapeutic benefits and associated risks.

Methods

A comprehensive literature review was conducted using the Cochrane, Google Scholar, PubMed, Science Direct, ClinicalTrials.gov, and Scopus databases, adhering to PRISMA guidelines. Study quality was evaluated using the Risk of Bias for Randomized Trials (RoB 2.0) tool.

Results

Aromatase Inhibitors function by inhibiting the aromatase enzyme, effectively reducing estrogen production. While they can be used with other therapies such as metformin or saracatinib, these combinations are not significantly more effective. Aromatase Inhibitors have been shown to enhance cognitive function and alleviate some depressive symptoms, although they may increase the risk of depression and anxiety in some patients.

Conclusion

Aromatase Inhibitors are an effective treatment for HR+ breast cancer in postmenopausal women. However, the potential psychological side effects, such as depression and anxiety, require careful management during therapy.

Zitieren

APA

Perdiyana, A., Lesmana, A., Sitompul, D. S. A., Wijayanti, F. A., Alrasyid, M. D., Wiguna, N. Y. R., Sutomo, T. N. S., Nugraha, D., & Fitriani, E. (2024). Assessing the Effectiveness of Hormonal Aromatase inhibitors (AI) Therapy in Hormone Receptor Positive Post-Menopausal Breast Cancer Patients: A Systematic Review. Bali Medical and Wellness Journal. https://doi.org/10.71341/bmwj.v1i2.7

Vancouver

Perdiyana A, Lesmana A, Sitompul DSA, Wijayanti FA, Alrasyid MD, Wiguna NYR, et al. Assessing the Effectiveness of Hormonal Aromatase inhibitors (AI) Therapy in Hormone Receptor Positive Post-Menopausal Breast Cancer Patients: A Systematic Review. Bali Medical and Wellness Journal. 2024. doi:10.71341/bmwj.v1i2.7

BibTeX
@article{Perdiyana2024,
  author = {Perdiyana, Angki and Lesmana, Agri and Sitompul, Dea Syafira Alamsyah and Wijayanti, Fakhira Ayu and Alrasyid, Miko Dharma and Wiguna, Naufal Yafi Rais and Sutomo, Tharisa Novianti Syabania and Nugraha, Deity and Fitriani, Elies},
  title = {Assessing the Effectiveness of Hormonal Aromatase inhibitors (AI) Therapy in Hormone Receptor Positive Post-Menopausal Breast Cancer Patients: A Systematic Review},
  journal = {Bali Medical and Wellness Journal},
  year = {2024},
  doi = {10.71341/bmwj.v1i2.7}
}
Kostenlos starten →